pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
STAT·5h ago·1 min read
save

NSF launches $47 million pilot to create joint university-industry Ph.D. programs for life scientists

Jul 29, 2026·read at STAT ↗Positive

The National Science Foundation, with funding announced by the Trump administration, is testing a new Ph.D. training model that blends academic study with industry experience.

The $47 million pilot will support four‑year Ph.D. programs jointly funded by universities and industry partners, requiring participants to spend at least one year conducting research at a company site.

Around 30 university‑industry pairs plan to take part, including the University of California‑San Diego, Northwestern, Purdue and Columbia, alongside companies such as Agilent Technologies, DuPont and Bayer Crop Science.

The effort responds to a growing trend of early‑career scientists leaving academia and aims to broaden career pathways in the life‑science sector.

source

This writeup was produced by pharmadog from original reporting by STAT.

Original headline: “NSF testing new Ph.D. model giving trainees academic and industry experience”

read at STAT ↗
1,140 words · retrieved 5h ago
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

no entities indexed yet

related stories

  • 6h agoSTAT+: Latigo reports mid-stage success for would-be rival to Vertex’s pain drug JournavxSTAT
  • 8h agoSTAT+: Hims misled consumers and violated their privacy, FTC alleges in a lawsuitSTAT
  • 12h agoSTAT+: End of Medicare drug subsidy gives Democrats new attack line on rising out-of-pocket costsSTAT
  • 13h agoSTAT+: Pharmalittle: We’re reading about a fugitive who became a biotech exec, a hospital suing Lilly, and moreSTAT
  • 13h agoSTAT+: Why benchmarking clinical LLMs from OpenEvidence, Doximity is complicatedSTAT